CN Stock MarketDetailed Quotes

002728 Teyi Pharmaceutical Group

Watchlist

9.23
+0.37+4.18%

Not Open Nov 26 15:00 CST

4.71BMarket Cap66.88P/E (TTM)

Teyi Pharmaceutical Group Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Operating Cash Flow

Goods sale service render cash

-28.07%462.72M

-26.25%330.87M

-30.26%163.08M

-2.65%925.02M

6.65%643.33M

19.52%448.65M

40.63%233.85M

24.39%950.22M

3.04%603.23M

-8.36%375.39M

Cash received relating to other operating activities

-51.34%8.27M

-60.41%5.55M

91.58%4.2M

-1.99%21.31M

-11.44%16.99M

-17.39%14.03M

-69.18%2.19M

79.85%21.74M

136.10%19.18M

150.74%16.98M

Cash inflows from operating activities

-28.67%470.99M

-27.29%336.42M

-29.13%167.28M

-2.64%946.32M

6.09%660.31M

17.92%462.67M

36.13%236.04M

25.25%971.96M

4.87%622.41M

-5.78%392.37M

Goods services cash paid

-2.57%258.72M

14.01%198.89M

-2.51%91.68M

17.37%350.82M

-0.08%265.53M

3.00%174.46M

29.51%94.04M

25.40%298.89M

19.63%265.74M

11.47%169.38M

Staff behalf paid

-5.64%78.46M

-6.95%54.3M

-18.14%29.46M

20.62%108.42M

22.17%83.15M

25.36%58.36M

42.23%35.98M

4.15%89.88M

5.62%68.05M

6.16%46.55M

All taxes paid

-42.49%47.86M

-39.69%41.71M

7.65%36.87M

51.00%101.92M

79.21%83.22M

99.87%69.17M

73.97%34.25M

-0.65%67.5M

-3.08%46.44M

3.30%34.61M

Cash paid relating to other operating activities

-20.48%124.23M

-17.73%84.18M

8.45%48.65M

29.57%186.61M

35.79%156.21M

37.33%102.33M

53.83%44.86M

13.78%144.03M

26.03%115.04M

7.61%74.51M

Cash outflows from operating activities

-13.41%509.26M

-6.24%379.09M

-1.18%206.65M

24.56%747.77M

18.74%588.11M

24.38%404.31M

42.50%209.13M

15.62%600.3M

16.33%495.27M

8.88%325.05M

Net cash flows from operating activities

-153.01%-38.27M

-173.11%-42.67M

-246.31%-39.38M

-46.58%198.56M

-43.21%72.21M

-13.30%58.37M

1.02%26.91M

44.72%371.66M

-24.22%127.14M

-42.89%67.32M

Investing cash flow

Cash received from returns on investments

602.52%1.9M

--1.05M

--21.47K

6.29%360.81K

-20.44%270.08K

----

-94.62%339.46K

-95.84%262.39K

Net cash received from disposal of fix assets、 intangible assets 、other long-term asset

-98.10%2.94K

-99.29%1.1K

--500

65.48%155.14K

67.04%155.14K

144.43%153.99K

----

-82.02%93.75K

2,606.18%92.88K

--63K

Cash received relating to other investing activities

--477.01M

--250.01M

--20M

82.50%73M

----

-85.71%40M

-89.29%30M

Cash inflows from investing activities

112,525.90%478.91M

162,934.99%251.06M

--20.02M

81.82%73.52M

-98.95%425.22K

-99.49%153.99K

----

-86.20%40.43M

-85.88%40.43M

-89.41%30.33M

Cash paid to acquire fixed assets intangible assets and other long-term assets

24.61%76.64M

36.33%62.66M

23.86%23.82M

-4.67%86.05M

6.68%61.51M

12.81%45.96M

-1.92%19.24M

-17.62%90.26M

-33.57%57.65M

-19.63%40.74M

Cash paid to acquire investments

----

116.00%13.5M

Cash paid relating to other investing activities

5,223.15%692.01M

--357.01M

--43.01M

82.50%73M

-67.50%13M

----

33.33%40M

Cash outflows from investing activities

931.67%768.65M

813.13%419.67M

247.46%66.83M

10.63%159.05M

-32.97%74.51M

-51.23%45.96M

-69.52%19.24M

-1.41%143.76M

-9.65%111.15M

8.39%94.24M

Net cash flows from investing activities

-291.12%-289.74M

-268.10%-168.61M

-143.37%-46.81M

17.23%-85.53M

-4.75%-74.08M

28.34%-45.81M

69.52%-19.24M

-170.17%-103.33M

-143.31%-70.72M

-132.06%-63.92M

Financing cash flow

Cash received from capital contributions

-95.31%13.28M

-4.57%13.28M

-7.21%12.92M

--282.83M

--283.2M

--13.92M

----

Cash from borrowing

92.94%820M

63.76%450.35M

260.00%180M

-17.92%626.63M

-44.36%425M

-58.21%275M

-78.17%50M

76.37%763.45M

72.43%763.88M

73.39%658M

Cash received relating to other financing activities

140.00%480M

50.00%300M

--100M

--200M

----

Cash inflows from financing activities

44.60%1.31B

56.19%763.63M

358.26%292.92M

45.32%1.11B

18.89%908.2M

-25.70%488.92M

-72.09%63.92M

23.58%763.45M

72.43%763.88M

73.39%658M

Borrowing repayment

-29.43%486M

-43.21%306M

73.04%190M

86.82%965.88M

36.10%688.68M

20.54%538.8M

-64.23%109.8M

-38.17%517M

-31.17%506M

-31.77%447M

Dividend interest payment

23.13%187.78M

20.29%182.37M

141.29%1.39M

0.95%149.02M

-1.38%152.5M

-1.08%151.61M

-76.04%575.08K

6.67%147.62M

7.25%154.64M

7.57%153.26M

Cash payments relating to other financing activities

477.86%577.86M

--413.98M

--180M

-50.00%100M

----

--200M

Cash outflows from financing activities

32.99%1.25B

30.70%902.35M

236.48%371.39M

40.51%1.21B

9.36%941.18M

-13.73%690.41M

-64.33%110.38M

-11.28%864.62M

-2.12%860.64M

0.33%800.26M

Net cash flows from financing activities

286.92%61.65M

31.15%-138.72M

-68.92%-78.47M

-4.22%-105.44M

65.91%-32.98M

-41.63%-201.49M

42.22%-46.46M

71.64%-101.17M

77.82%-96.76M

65.97%-142.26M

Net cash flow

Net increase in cash and cash equivalents

-664.26%-266.37M

-85.26%-350M

-324.61%-164.66M

-95.46%7.59M

13.59%-34.85M

-36.06%-188.93M

66.82%-38.78M

253.16%167.16M

61.67%-40.34M

-37.69%-138.86M

Add:Begin period cash and cash equivalents

1.41%546.82M

44.93%539.23M

14.58%372.07M

End period cash equivalent

-44.40%280.45M

-43.82%196.81M

-23.64%382.15M

1.41%546.82M

52.04%504.38M

50.21%350.3M

96.10%500.45M

44.93%539.23M

51.13%331.74M

4.16%233.21M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Daxin Certified Public Accountants (Special General Partnership)

Lixin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash	-28.07%462.72M	-26.25%330.87M	-30.26%163.08M	-2.65%925.02M	6.65%643.33M	19.52%448.65M	40.63%233.85M	24.39%950.22M	3.04%603.23M	-8.36%375.39M
Cash received relating to other operating activities	-51.34%8.27M	-60.41%5.55M	91.58%4.2M	-1.99%21.31M	-11.44%16.99M	-17.39%14.03M	-69.18%2.19M	79.85%21.74M	136.10%19.18M	150.74%16.98M
Cash inflows from operating activities	-28.67%470.99M	-27.29%336.42M	-29.13%167.28M	-2.64%946.32M	6.09%660.31M	17.92%462.67M	36.13%236.04M	25.25%971.96M	4.87%622.41M	-5.78%392.37M
Goods services cash paid	-2.57%258.72M	14.01%198.89M	-2.51%91.68M	17.37%350.82M	-0.08%265.53M	3.00%174.46M	29.51%94.04M	25.40%298.89M	19.63%265.74M	11.47%169.38M
Staff behalf paid	-5.64%78.46M	-6.95%54.3M	-18.14%29.46M	20.62%108.42M	22.17%83.15M	25.36%58.36M	42.23%35.98M	4.15%89.88M	5.62%68.05M	6.16%46.55M
All taxes paid	-42.49%47.86M	-39.69%41.71M	7.65%36.87M	51.00%101.92M	79.21%83.22M	99.87%69.17M	73.97%34.25M	-0.65%67.5M	-3.08%46.44M	3.30%34.61M
Cash paid relating to other operating activities	-20.48%124.23M	-17.73%84.18M	8.45%48.65M	29.57%186.61M	35.79%156.21M	37.33%102.33M	53.83%44.86M	13.78%144.03M	26.03%115.04M	7.61%74.51M
Cash outflows from operating activities	-13.41%509.26M	-6.24%379.09M	-1.18%206.65M	24.56%747.77M	18.74%588.11M	24.38%404.31M	42.50%209.13M	15.62%600.3M	16.33%495.27M	8.88%325.05M
Net cash flows from operating activities	-153.01%-38.27M	-173.11%-42.67M	-246.31%-39.38M	-46.58%198.56M	-43.21%72.21M	-13.30%58.37M	1.02%26.91M	44.72%371.66M	-24.22%127.14M	-42.89%67.32M
Investing cash flow
Cash received from returns on investments	602.52%1.9M	--1.05M	--21.47K	6.29%360.81K	-20.44%270.08K	----	----	-94.62%339.46K	-94.62%339.46K	-95.84%262.39K
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset	-98.10%2.94K	-99.29%1.1K	--500	65.48%155.14K	67.04%155.14K	144.43%153.99K	----	-82.02%93.75K	2,606.18%92.88K	--63K
Cash received relating to other investing activities	--477.01M	--250.01M	--20M	82.50%73M	----	----	----	-85.71%40M	-85.71%40M	-89.29%30M
Cash inflows from investing activities	112,525.90%478.91M	162,934.99%251.06M	--20.02M	81.82%73.52M	-98.95%425.22K	-99.49%153.99K	----	-86.20%40.43M	-85.88%40.43M	-89.41%30.33M
Cash paid to acquire fixed assets intangible assets and other long-term assets	24.61%76.64M	36.33%62.66M	23.86%23.82M	-4.67%86.05M	6.68%61.51M	12.81%45.96M	-1.92%19.24M	-17.62%90.26M	-33.57%57.65M	-19.63%40.74M
Cash paid to acquire investments	----	----	----	----	----	----	----	116.00%13.5M	116.00%13.5M	116.00%13.5M
Cash paid relating to other investing activities	5,223.15%692.01M	--357.01M	--43.01M	82.50%73M	-67.50%13M	----	----	33.33%40M	33.33%40M	33.33%40M
Cash outflows from investing activities	931.67%768.65M	813.13%419.67M	247.46%66.83M	10.63%159.05M	-32.97%74.51M	-51.23%45.96M	-69.52%19.24M	-1.41%143.76M	-9.65%111.15M	8.39%94.24M
Net cash flows from investing activities	-291.12%-289.74M	-268.10%-168.61M	-143.37%-46.81M	17.23%-85.53M	-4.75%-74.08M	28.34%-45.81M	69.52%-19.24M	-170.17%-103.33M	-143.31%-70.72M	-132.06%-63.92M
Financing cash flow
Cash received from capital contributions	-95.31%13.28M	-4.57%13.28M	-7.21%12.92M	--282.83M	--283.2M	--13.92M	--13.92M	----	----	----
Cash from borrowing	92.94%820M	63.76%450.35M	260.00%180M	-17.92%626.63M	-44.36%425M	-58.21%275M	-78.17%50M	76.37%763.45M	72.43%763.88M	73.39%658M
Cash received relating to other financing activities	140.00%480M	50.00%300M	--100M	--200M	--200M	--200M	----	----	----	----
Cash inflows from financing activities	44.60%1.31B	56.19%763.63M	358.26%292.92M	45.32%1.11B	18.89%908.2M	-25.70%488.92M	-72.09%63.92M	23.58%763.45M	72.43%763.88M	73.39%658M
Borrowing repayment	-29.43%486M	-43.21%306M	73.04%190M	86.82%965.88M	36.10%688.68M	20.54%538.8M	-64.23%109.8M	-38.17%517M	-31.17%506M	-31.77%447M
Dividend interest payment	23.13%187.78M	20.29%182.37M	141.29%1.39M	0.95%149.02M	-1.38%152.5M	-1.08%151.61M	-76.04%575.08K	6.67%147.62M	7.25%154.64M	7.57%153.26M
Cash payments relating to other financing activities	477.86%577.86M	--413.98M	--180M	-50.00%100M	-50.00%100M	----	----	--200M	--200M	--200M
Cash outflows from financing activities	32.99%1.25B	30.70%902.35M	236.48%371.39M	40.51%1.21B	9.36%941.18M	-13.73%690.41M	-64.33%110.38M	-11.28%864.62M	-2.12%860.64M	0.33%800.26M
Net cash flows from financing activities	286.92%61.65M	31.15%-138.72M	-68.92%-78.47M	-4.22%-105.44M	65.91%-32.98M	-41.63%-201.49M	42.22%-46.46M	71.64%-101.17M	77.82%-96.76M	65.97%-142.26M
Net cash flow
Net increase in cash and cash equivalents	-664.26%-266.37M	-85.26%-350M	-324.61%-164.66M	-95.46%7.59M	13.59%-34.85M	-36.06%-188.93M	66.82%-38.78M	253.16%167.16M	61.67%-40.34M	-37.69%-138.86M
Add:Begin period cash and cash equivalents	1.41%546.82M	1.41%546.82M	1.41%546.82M	44.93%539.23M	44.93%539.23M	44.93%539.23M	44.93%539.23M	14.58%372.07M	14.58%372.07M	14.58%372.07M
End period cash equivalent	-44.40%280.45M	-43.82%196.81M	-23.64%382.15M	1.41%546.82M	52.04%504.38M	50.21%350.3M	96.10%500.45M	44.93%539.23M	51.13%331.74M	4.16%233.21M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

002728 Teyi Pharmaceutical Group

Teyi Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target